Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

NCT06039748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2025-05-16

No results posted yet for this study

Summary

Coronary angiography-derived FFR assessment (AngioQFA) is a novel technique for physiological lesion assessment based on 3-dimensional (3D) quantitative coronary angiography (QCA) and virtual hyperemic flow derived from contrast frame count without drug-induced hyperemia. The goal of this prospective, multicenter trial is to compare the diagnostic performance of AngioQFA with invasive FFR as the reference standard. The secondary purpose is to compare the diagnostic accuracies of the computational fluid dynamics (CFD)-based index of microcirculatory resistance (IMR) using wire-based IMR as the reference standard.

Conditions

Interventions

OTHER

AngioQFA

FFR measured by pressure wire, AngioQFA computed by coronary angiographic images

Sponsors & Collaborators

  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Yan'an Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Jieyang People's Hospital

    collaborator OTHER
  • Eighth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Shenzhen Raysight Intelligent Medical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Hong Jiang · Renmin Hospital of Wuhan University

  • Qiang Xue · Yan'an Affiliated Hospital of Kunming Medical University

  • Guosheng Fu · Sir Run Run Shaw Hospital

  • Jianwen Liang · The Eighth Affiliated Hospital of Sun Yat-sen University

  • Qiang Wu · Jieyang People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-13
Primary Completion
2024-01-14
Completion
2024-01-14

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06039748 on ClinicalTrials.gov